Detalles de la búsqueda
1.
Androgen deprivation therapy-related fracture risk in prostate cancer: an insurance claims database study in Japan.
J Bone Miner Metab
; 42(2): 223-232, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38493435
2.
Targeting FoxO transcription factors with HDAC inhibitors for the treatment of osteoarthritis.
Ann Rheum Dis
; 82(2): 262-271, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36109140
3.
Denosumab improves bone mineral density and microarchitecture in rheumatoid arthritis: randomized controlled trial by HR-pQCT.
J Bone Miner Metab
; 41(6): 797-806, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37480398
4.
Effect of quantitative partial valgus stress during baseball pitching on ball velocity and subjective pitch-effort.
J Shoulder Elbow Surg
; 32(1): 168-173, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36179959
5.
Safety and effectiveness of denosumab in Japanese patients with rheumatoid arthritis: a 2-year post-marketing surveillance study.
Mod Rheumatol
; 2023 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38048431
6.
Fracture risk associated with glucocorticoid-induced osteoporosis in Japan.
J Bone Miner Metab
; 40(4): 636-647, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35546370
7.
Analysis of factors contributing to medication errors during self-management of medication in the rehabilitation ward: a case control study.
BMC Health Serv Res
; 22(1): 292, 2022 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35241078
8.
Phase II study of temozolomide monotherapy in patients with extrapulmonary neuroendocrine carcinoma.
Cancer Sci
; 112(5): 1936-1942, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33453146
9.
Elobixibat Effectively Relieves Chronic Constipation in Patients with Cancer Regardless of the Amount of Food Intake.
Oncologist
; 26(10): e1862-e1869, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34180099
10.
Long-term safety and effectiveness of denosumab in Japanese patients with osteoporosis: 3-year post-marketing surveillance study.
J Bone Miner Metab
; 39(3): 463-473, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33387064
11.
Epidemiology of glucocorticoid-induced osteoporosis and management of associated fracture risk in Japan.
J Bone Miner Metab
; 39(6): 1019-1030, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34125296
12.
Predictors of new bone erosion in rheumatoid arthritis patients receiving conventional synthetic disease-modifying antirheumatic drugs: Analysis of data from the DRIVE and DESIRABLE studies.
Mod Rheumatol
; 31(1): 34-41, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31826682
13.
Relationship Between Bone Mineral Density and Risk of Vertebral Fractures with Denosumab Treatment in Japanese Postmenopausal Women and Men with Osteoporosis.
Calcif Tissue Int
; 107(6): 559-566, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32839843
14.
Efficacy of denosumab co-administered with vitamin D and Ca by baseline vitamin D status.
J Bone Miner Metab
; 38(6): 848-858, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32671481
15.
Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial.
Ann Rheum Dis
; 78(7): 899-907, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31036625
16.
Efficacy of denosumab with regard to bone destruction in prognostic subgroups of Japanese rheumatoid arthritis patients from the phase II DRIVE study.
Rheumatology (Oxford)
; 58(6): 997-1005, 2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30602032
17.
[Clinical classification of fall risk using visually obtained information at a memory clinic].
Nihon Ronen Igakkai Zasshi
; 56(2): 164-170, 2019.
Artículo
en Japonés
| MEDLINE | ID: mdl-31092782
18.
Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)-a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial.
Ann Rheum Dis
; 75(6): 983-90, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26585988
19.
Parathyroid hormone resets the cartilage circadian clock of the organ-cultured murine femur.
Acta Orthop
; 86(5): 627-31, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25765847
20.
Osteoporotic fracture risk in women with breast cancer treated with aromatase inhibitors: a health insurance claims database study in Japan.
Expert Opin Pharmacother
; 25(3): 325-334, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38588537